Response of growing swine to dietary exposure to pure fumonisin B1 during an eight‐week period: Growth and clinical parameters
- 1 January 1996
- journal article
- research article
- Published by Wiley in Natural Toxins
- Vol. 4 (1) , 42-50
- https://doi.org/10.1002/19960401nt6
Abstract
Consumption of corn or corn‐based products contaminated with Fusarium moniliforme/fumonisins has been associated with a variety of animal and human diseases and is a major food/feed safety issue. This study focused on the clinical toxicity and performance parameters in growing swing exposed to low to moderate levels of pure fumonisin B1 (FB1) for 8 weeks. Male (castrated) and female pigs were fed diets containing 0, 0.1, 1.0, and 10 mg FB1/kg diet (ppm). Weight gains and feed consumption were measured weekly. Blood samples were collected throughout the study, and various clinical and hematological parameters were measured. Because fumonisins are potent inhibitors of sphingolipid biosynthesis, sphinganine and sphingosine concentrations were determined in the liver, lung, and kidney. Organ weights and carcass quality were measured at the end of the trial. In general, male pigs were more adversely affected by FB1 in the diet than females. The average daily gain for males decreased by 8% for pigs fed 1.0 ppm and by 11% at 10.0 ppm, when compared to the control (0 ppm). Males fed 0.1 ppm showed an erratic growth pattern during the first 5 weeks of the experiment. Feed consumption for the same animals was somewhat higher than that of the controls during each of the first 4 weeks but thereafter was 6–7% lower each week as compared to controls. Female pigs fed FB1‐diets showed a general enhancement of feed consumption until week 4. Among clinical chemistry parameters, cholesterol increased in males for the 1.0 and 10.0 ppm diets as compared to controls after 2 weeks, while the levels in both sexes were elevated for the 1.0 ppm diet only by the end of the experiment. Serum liver enzyme concentrations were altered during week 2 only. Changes were observed in the weight of the pancreas and adrenals for male pigs fed FB1 diets as compared to controls. The free sphinganine to free sphingosine ratio (biomarker of exposure in FB1‐consuming animals) increased in all three organs for the 10 ppm diet, regardless of sex. The study indicated that FB1 can cause different effects at each dose level, at concentrations as low as 0.1 ppm (showing erratic growth) followed by a reduced growth and biochemical abnormalities in blood (1.0 ppm) and sphingolipid alterations in tissues (10.0 ppm). Some of these effects occurred below the exposure level that caused alteration in sphingolipid metabolism. c̊ 1996 Wiley‐Liss, IncKeywords
This publication has 38 references indexed in Scilit:
- Disposition of14C‐derived residues in tissues of pigs fed radiolabelled fumonisin B1Food Additives & Contaminants, 1996
- Chronic Effects of Dietary Fumonisin on the Heart and Pulmonary Vasculature of SwineFundamental and Applied Toxicology, 1994
- Influence of Low-Level Exposure to Fusarium Mycotoxins on Selected Immunological and Hematological Parameters in Young SwineFundamental and Applied Toxicology, 1994
- Temporal and dose-response features in swine fed corn screenings contaminated with fumonisin mycotoxinsMycopathologia, 1994
- Ear rot development and mycotoxin production in corn in relation to inoculation method, corn hybrid, and species ofFusariumCanadian Journal of Plant Pathology, 1993
- Chronic Toxicity of Fumonisin in Weanling PigsJournal of Veterinary Diagnostic Investigation, 1993
- Fumonisin B1, B2, and B3 content of Iowa, Wisconsin, and Illinois corn and corn screeningsJournal of Agricultural and Food Chemistry, 1993
- Atherogenic effects in a non-human primate of cultures added to a carbohydrate dietAtherosclerosis, 1992
- A preliminary examination of potential interactions between deoxynivalenol (DON) and other selected Fusarium metabolites in growing pigsCanadian Journal of Animal Science, 1992
- Fusarium moniliformeand Fumonisins in Corn in Relation to Human Esophageal Cancer in TranskeiPhytopathology®, 1992